SEARCH

SEARCH BY CITATION

References

  • Allen N. J., Bennett M. L., Foo L. C., Wang G. X., Chakraborty C., Smith S. J. and Barres B. A. (2012) Astrocyte glypicans 4 and 6 promote formation of excitatory synapses via GluA1 AMPA receptors. Nature 486, 410414.
  • Bacq A., Balasse L., Biala G. et al. (2012) Organic cation transporter 2 controls brain norepinephrine and serotonin clearance and antidepressant response. Mol. Psychiatry 17, 926939.
  • Baganz N. L., Horton R. E., Calderon A. S. et al. (2008) Organic cation transporter 3: keeping the brake on extracellular serotonin in serotonin-transporter-deficient mice. Proc. Natl Acad. Sci. USA 105, 1897618981.
  • Bunin M. A. and Wightman R. M. (1998) Quantitative evaluation of 5-hydroxytryptamine (serotonin) neuronal release and uptake: an investigation of extrasynaptic transmission. J. Neurosci. 18, 48544860.
  • Busch A. E., Karbach U., Miska D., et al. (1998) Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine. Mol. Pharmacol. 54, 342352.
  • Cheetham S. C., Viggers J. A., Butler S. A., Prow M. R. and Heal D. J. (1996) [3H]nisoxetine–a radioligand for noradrenaline reuptake sites: correlation with inhibition of [3H]noradrenaline uptake and effect of DSP-4 lesioning and antidepressant treatments. Neuropharmacology 35, 6370.
  • Cui M., Aras R., Christian W. V. et al. (2009) The organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathway. Proc. Natl Acad. Sci. USA 106, 80438048.
  • Duan H. and Wang J. (2010) Selective transport of monoamine neurotransmitters by human plasma membrane monoamine transporter and organic cation transporter 3. J. Pharmacol. Exp. Ther. 335, 743753.
  • Duan H. and Wang J. (2013) Impaired monoamine and organic cation uptake in choroid plexus in mice with targeted disruption of the plasma membrane monoamine transporter (Slc29a4) gene. J. Biol. Chem. 288, 35353544.
  • Engel K., Zhou M. and Wang J. (2004) Identification and characterization of a novel monoamine transporter in the human brain. J. Biol. Chem. 279, 5004250049.
  • Fava M. and Davidson K. G. (1996) Definition and epidemiology of treatment-resistant depression. Psychiatr. Clin. North Am. 19, 179200.
  • Fitzgerald L. W., Kaplinsky L. and Kimelberg H. K. (1990) Serotonin metabolism by monoamine oxidase in rat primary astrocyte cultures. J. Neurochem. 55, 20082014.
  • Frampton J. E. and Plosker G. L. (2007) Duloxetine: a review of its use in the treatment of major depressive disorder. CNS Drugs 21, 581609.
  • Hagino Y., Takamatsu Y., Yamamoto H., Iwamura T., Murphy D. L., Uhl G. R., Sora I. and Ikeda K. (2011) Effects of MDMA on extracellular dopamine and serotonin levels in mice lacking dopamine and/or serotonin transporters. Curr. Neuropharmacol. 9, 9195.
  • Hansson E. and Sellstrom A. (1983) MAO COMT, and GABA-T activities in primary astroglial cultures. J. Neurochem. 40, 220225.
  • Hirst W. D., Price G. W., Rattray M. and Wilkin G. P. (1998) Serotonin transporters in adult rat brain astrocytes revealed by [3H]5-HT uptake into glial plasmalemmal vesicles. Neurochem. Int. 33, 1122.
  • Inazu M., Takeda H., Ikoshi H., Sugisawa M., Uchida Y. and Matsumiya T. (2001) Pharmacological characterization and visualization of the glial serotonin transporter. Neurochem. Int. 39, 3949.
  • Inazu M., Takeda H. and Matsumiya T. (2003a) Functional expression of the norepinephrine transporter in cultured rat astrocytes. J. Neurochem. 84, 136144.
  • Inazu M., Takeda H. and Matsumiya T. (2003b) The role of glial monoamine transporters in the central nervous system. Nihon Shinkei Seishin Yakurigaku Zasshi 23, 171178.
  • Jensen N. H., Rodriguiz R. M., Caron M. G., Wetsel W. C., Rothman R. B. and Roth B. L. (2008) N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity. Neuropsychopharmacology 33, 23032312.
  • Kandel E. R., Schwartz J. H. and Jessell T. M. (2013) Principles of Neural Science, Fifth Edition: principles of neural science. The McGraw Hill Companies, New York.
  • Koepsell H., Lips K. and Volk C. (2007) Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications. Pharm. Res. 24, 12271251.
  • Kristensen A. S., Andersen J., Jorgensen T. N., Sorensen L., Eriksen J., Loland C. J., Stromgaard K. and Gether U. (2011) SLC6 neurotransmitter transporters: structure, function, and regulation. Pharmacol. Rev. 63, 585640.
  • Nakanishi T., Hatanaka T., Huang W., Prasad P. D., Leibach F. H., Ganapathy M. E. and Ganapathy V. (2001) Na+- and Cl–coupled active transport of carnitine by the amino acid transporter ATB(0,+) from mouse colon expressed in HRPE cells and Xenopus oocytes. J. Physiol. 532, 297304.
  • Oberheim N. A., Takano T., Han X., et al. (2009) Uniquely hominid features of adult human astrocytes. J. Neurosci. 29, 32763287.
  • Owens M. J., Morgan W. N., Plott S. J. and Nemeroff C. B. (1997) Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. J. Pharmacol. Exp. Ther. 283, 13051322.
  • Pelton E. W., 2nd, Kimelberg H. K., Shipherd S. V. and Bourke R. S. (1981) Dopamine and norepinephrine uptake and metabolism by astroglial cells in culture. Life Sci. 28, 16551663.
  • Perdan-Pirkmajer K., Mavri J. and Krzan M. (2010) Histamine (re)uptake by astrocytes: an experimental and computational study. J. Mol. Model. 16, 11511158.
  • Russ H., Staust K., Martel F., Gliese M. and Schomig E. (1996) The extraneuronal transporter for monoamine transmitters exists in cells derived from human central nervous system glia. Eur. J. Neurosci. 8, 12561264.
  • Schousboe A., Sarup A., Bak L. K., Waagepetersen H. S. and Larsson O. M. (2004) Role of astrocytic transport processes in glutamatergic and GABAergic neurotransmission. Neurochem. Int. 45, 521527.
  • Sofroniew M. V. and Vinters H. V. (2010) Astrocytes: biology and pathology. Acta Neuropathol. 119, 735.
  • Takeda H., Inazu M. and Matsumiya T. (2002) Astroglial dopamine transport is mediated by norepinephrine transporter. Naunyn Schmiedeberg's Arch. Pharmacol. 366, 620623.
  • Taubert D., Grimberg G., Stenzel W. and Schomig E. (2007) Identification of the endogenous key substrates of the human organic cation transporter OCT2 and their implication in function of dopaminergic neurons. PLoS ONE 2, e385.
  • Torres G. E., Gainetdinov R. R. and Caron M. G. (2003) Plasma membrane monoamine transporters: structure, regulation and function. Nat. Rev. Neurosci. 4, 1325.
  • Trivedi M. H., Rush A. J., Wisniewski S. R. et al. (2006) Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am. J. Psychiatry 163, 2840.
  • Volterra A. and Meldolesi J. (2005) Astrocytes, from brain glue to communication elements: the revolution continues. Nat. Rev. Neurosci. 6, 626640.
  • Yoshikawa T., Naganuma F., Iida T., Nakamura T., Harada R., Mohsen A. S., Kasajima A., Sasano H. and Yanai K. (2013) Molecular mechanism of histamine clearance by primary human astrocytes. Glia 61, 905916.